Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma shows promise for treating erectile dysfunction, but more research is needed.

Dutasteride is approved to help manage prostate enlargement.

Dutasteride and finasteride don't raise erectile dysfunction risk.

PRP injections are not proven effective for treating erectile dysfunction.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Finasteride reduces bleeding risk during prostate surgery.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

Taking sildenafil and finasteride together is safe and improves urinary and sexual symptoms in BPH patients.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Nifedipine may help treat perniosis, improving symptoms and clearing lesions for some patients.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Pterostilbene significantly reduces prostate enlargement and has strong antioxidant effects.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.